Suchergebnisse - "Siderowf, Andrew D"

PubPharm (72)

1

Evaluation of ATNPD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease

enthalten in: Neurology | 2024

von Cousins, K. | Irwin, D. | Tropea, T. | +20

2

Trial of Cinpanemab in Early Parkinson's Disease

enthalten in: The New England journal of medicine | 2022

von Lang, A. | Siderowf, A. | Macklin, E. | +99

3

The importance of preclinical diagnostics in Parkinson disease

enthalten in: Parkinsonism & related disorders | 2019

von Mantri, S. | Morley, J. | Siderowf, A.

4

Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders

enthalten in: Annals of neurology | 2019

von Coughlin, D. | Xie, S. | Liang, M. | +17

5

O5‐03‐04 : THE LEWY BODY DEMENTIA ASSOCIATION RESEARCH CENTERS OF EXCELLENCE PROGRAM: TOWARD OPTIMIZING CLINICAL CARE AND CLINICAL TRIAL INFRASTRUCTURE

enthalten in: Alzheimer's & Dementia | 2018

von Boeve, B. | Armstrong, M. | Galvin, J. | +42

6

Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia

enthalten in: PloS one | 2017

von Akhtar, R. | Xie, S. | Chen, Y. | +10

7

[P2–383] : COMPARISON OF REGIONAL FLORTAUCIPIR PET TO QUANTITATIVE TAU AND AMYLOID IMMUNOASSAY IN PATIENTS WITH ALZHEIMER's DISEASE PATHOLOGY: A PILOT CLINICO‐PATHOLOGICAL STUDY

enthalten in: Alzheimer's & Dementia | 2017

von Siderowf, A. | Dirk Keene, C. | Beach, T. | +14

8

[P4–530] : MODELING OF TAU TRAJECTORIES ACROSS THE ALZHEIMER's DISEASE SPECTRUM USING [18F]‐FLORTAUCIPIR PET IMAGING

enthalten in: Alzheimer's & Dementia | 2017

von Shcherbinin, S. | Devous, M. | Lin, Q. | +9

9

Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia

enthalten in: Movement disorders clinical practice | 2016

von Akhtar, R. | Xie, S. | Brennan, L. | +5

10

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease : no evidence of benefit

enthalten in: JAMA neurology | 2014

von Parkinson Study Group QE3 Investigators | Beal, M. | Oakes, D. | +98

CommentIn: JAMA Neurol. 2014 May;71(5):537-8. - PMID 24664140

1
2
3
4
5
6
7
8
Nächster »
[8]